Cypress Capital Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-501
| Closed | -$271K | – | 316 |
|
|
2024
Q2 | $271K | Sell |
501
-30
| -6% | -$16.3K | 0.03% | 260 |
|
|
2024
Q1 | $275K | Sell |
531
-1,565
| -75% | -$812K | 0.03% | 259 |
|
|
2023
Q4 | $988K | Sell |
2,096
-226
| -10% | -$107K | 0.13% | 143 |
|
|
2023
Q3 | $1.01M | Buy |
2,322
+1,619
| +230% | +$705K | 0.15% | 132 |
|
|
2023
Q2 | $312K | Buy |
703
+10
| +1% | +$4.44K | 0.05% | 256 |
|
|
2023
Q1 | $319K | Hold |
693
| – | – | 0.05% | 244 |
|
|
2022
Q4 | $355K | Buy |
+693
| New | +$355K | 0.05% | 237 |
|
|
2022
Q1 | – | Sell |
-772
| Closed | -$358K | – | 314 |
|
|
2021
Q4 | $358K | Sell |
772
-290
| -27% | -$134K | 0.04% | 241 |
|
|
2021
Q3 | $396K | Sell |
1,062
-71
| -6% | -$26.5K | 0.05% | 227 |
|
|
2021
Q2 | $433K | Sell |
1,133
-2
| -0.2% | -$764 | 0.06% | 222 |
|
|
2021
Q1 | $407K | Sell |
1,135
-36
| -3% | -$12.9K | 0.06% | 224 |
|
|
2020
Q4 | $376K | Buy |
1,171
+21
| +2% | +$6.74K | 0.06% | 219 |
|
|
2020
Q3 | $309K | Sell |
1,150
-32
| -3% | -$8.6K | 0.05% | 217 |
|
|
2020
Q2 | $311K | Buy |
+1,182
| New | +$311K | 0.06% | 207 |
|
|
2018
Q2 | – | Sell |
-1,058
| Closed | -$232K | – | 228 |
|
|
2018
Q1 | $232K | Buy |
+1,058
| New | +$232K | 0.05% | 203 |
|